SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-23-009172
Filing Date
2023-08-22
Accepted
2023-08-22 11:30:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27666
2 filename2.txt TEXT-EXTRACT 1517
  Complete submission text file 0000000000-23-009172.txt   40421
Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Filed for) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)